Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-828 vs S-amlodipine in stage 2 hypertension
KCT0000501Phase 3Completed
- Sponsor
- Chong Kun Dang
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of telmisartan + s-amlodipine in essential hypertension (2 arms), sponsored by Chong Kun Dang. Started Jul 2012; status: completed.
02
Drugs
telmisartan + s-amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on KCT0000501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000501.